A phase 2 trial of Lundbeck’s alpha-synuclein-targeting drug Lu AF82422 has failed to reach statistical significance in patients with multiple system atrophy (MSA), although the company says there are ...
CND Life Sciences Inc, a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, announced that the US Food and Drug Administration ...
Fuchs Lubricants Co., the world’s largest independent lubricant supplier, has announced the release of RENOLIN FECC 10 SYN, a premium, single-phase immersion cooling fluid engineered to meet the ...
The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...
There is one phrase in Jon Voight‘s “Make Hollywood great again” plan that could upend the TV industry: “Restoration of the FINSYN Rule” for both broadcast networks and streamers. The document, which ...
Researchers from Aarhus University and Synuca Therapeutics recently presented a novel drug-like small-molecule inhibitor of sarco/endoplasmic reticulum calcium ATPase (SERCA), SYN-4569, with superior ...
Swap preamp modules in and out and pair them with onboard American-style clean channel for a compact three-channel powerhouse for stage and studio When you purchase through links on our site, we may ...
Syn-AKE is a synthetic tripeptide that emulates the active region of Waglerin-1, a venom component derived from the Temple Viper (Tropidolaemus wagleri). Syn-AKE is a synthetic tripeptide that ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results